Professor Zhengming Chen
- Epidemiology of autoimmune disease in Chinese adults
- Burden and risk factors of infectious complications among Chinese adults with diabetes
- Development of cardiovascular risk prediction model for Chinese adults
- Physical activity and risk of non-vascular chronic diseases in Chinese men and women
- Female reproductive history and risks of cancer and other diseases in a prospective cohort study of 300,000 Chinese women
- Phenome-wide association studies of functional genetic variants to identify and validate drug targets
- Medical Research Council Population Health Research Unit (MRC PHRU)
- Bone mineral density and osteoporosis: patterns, determinants and their relationships with cardiometabolic disorders in Chinese adults
- Patterns and risk factors of arthritis, fractures and other musculoskeletal disorders in 0.5 million Chinese adults
Professor of Epidemiology and Director of China Programmes
- Clinical Trial Service Unit and Epidemiological Studies Unit
Professor Zhengming Chen qualified in medicine at Shanghai Medical University in 1983 (now Fudan University), and gained his DPhil in Epidemiology at the University of Oxford in 1993. He was appointed as Professor of Epidemiology by the University of Oxford in 2006. He is now the Director of the China Programs at the Oxford University’s Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU) and co-executive director of the China Oxford Centre for International Health Research. His main researches focus on the environmental and genetic causes of chronic disease, evidence-based medicine and evaluation of widely practicable treatments for chronic diseases (such as IHD, stroke and cancer) as well as efficient strategies for chronic disease control in developing countries. Over the past 20 years, he has led several large randomised trials in heart disease (eg, COMMIT/CCS-2), stroke (eg, CAST) and cancer and 3 cohort studies involving >750,000 individuals. Since 2003 he has been the lead principal investigator in the UK for the China Kadoorie Biobank (CKB) prospective study of 0.5 million adults. He leads a research team in Oxford which is responsible for study design and development of procedures and IT systems for the CKB, and for central data management, curation and detailed analyses. He is an honorary professor of Peking Union Medical College and Fudan University in China.
Metabolic and lifestyle risk factors for acute pancreatitis in Chinese adults: A prospective cohort study of 0.5 million people.
Pang Y. et al, (2018), PLoS Med, 15
Diabetes, plasma glucose and incidence of colorectal cancer in Chinese adults: a prospective study of 0.5 million people.
Pang Y. et al, (2018), J Epidemiol Community Health
Association between major depressive episode and risk of type 2 diabetes: A large prospective cohort study in Chinese adults.
Meng R. et al, (2018), J Affect Disord, 234, 59 - 66
Chronic hepatitis B virus infection and risk of chronic kidney disease: a population-based prospective cohort study of 0.5 million Chinese adults.
Si J. et al, (2018), BMC Med, 16
Chronic hepatitis B virus infection and risk of chronic kidney disease: a population-based prospective cohort study of 0.5 million Chinese adults
Si J. et al, (2018), HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 16, 1 - 8